competitive

intelligence Services

Turning Insight into Action for Life Sciences Companies

In a rapidly evolving global life sciences landscape, real-time insight into your competitors’ strategies, regulatory positioning, market activities, and innovation pipelines can make the difference between market leadership and obsolescence.

EMMA International’s Competitive Intelligence (CI) service empowers pharmaceutical, biotechnology, and medical device companies with strategic intelligence solutions to outmaneuver competitors, mitigate risks, and capture untapped opportunities across regulated markets.

Whether preparing for a new product launch, navigating a crowded therapeutic area, responding to evolving regulatory expectations, or assessing M&A targets, EMMA International delivers tailored, actionable intelligence grounded in deep regulatory and technical expertise.

Our CI Capabilities

EMMA International’s Competitive Intelligence services go beyond surface-level data aggregation.

Regulatory Intelligence

Global Regulatory Landscape Mapping
Understand current and emerging regulations across FDA, EMA, MHRA, TGA, WHO PQ, and key LMICs.

Competitor Filing Intelligence
Analyze 510(k), PMA, NDA, ANDA, and IND submissions through FOIA requests, Health Canada filings, EU databases, and more.

Inspection and Enforcement Monitoring
Track FDA 483s, warning letters, and consent decrees to identify vulnerabilities and adjust quality strategies.

Clinical & Pipeline Intelligence

Clinical Trial Benchmarking
Assess trial design, endpoints, sites, timelines, and sponsors across ClinicalTrials.gov, EUCTR, and local registries.

Pipeline Tracking & Innovation Monitoring
Stay ahead of therapeutic innovation, biosimilar development, platform technologies, and next-gen delivery systems.

Market and Commercial Intelligence

Competitive Landscape Assessments
Understand positioning, differentiation, and white space across therapeutic areas and device classifications.

Product Launch Surveillance
Monitor market access pathways, pricing strategies, commercial partnerships, and regional expansion.

KOL & Thought Leader Mapping
Identify and analyze influence networks across academia, regulatory circles, and clinical practice.

Strategic Business Intelligence

M&A/Partnership Diligence
Conduct CI-driven assessments of potential partners, targets, or competitors.

Technology Transfer Intelligence
Analyze partner site history, regulatory compliance, and transfer success metrics for CDMOs and CROs.

Risk Profiling & Early Warning Systems
Anticipate emerging threats from new entrants, regulatory disruptions, or shifting patient/provider expectations.

Why EMMA International?

What sets EMMA International apart is not just our ability to collect information but our deep regulatory, technical, and market acumen that allows us to contextualize intelligence for real-world decision making.

Sector-Specific Expertise

We specialize exclusively in FDA-regulated industries, with clients spanning:

Pharmaceuticals (Rx and OTC)
Biologics and Cell/Gene Therapies
Medical Devices (Class I–III)
Combination Products and Diagnostics

Multidisciplinary Team

Our CI team includes:

Former FDA reviewers and auditors
Clinical operations and trial design experts
Regulatory strategy and global compliance consultants
Data scientists and FOIA specialists

Confidentiality and Customization

Every engagement is tailored to your strategic priorities. We operate with strict confidentiality and ethical compliance, ensuring integrity in every insight delivered.

Ready to turn intelligence into strategic advantage?

Whether you’re preparing for your next FDA submission, entering a new market, or responding to competitive threats, EMMA International brings the clarity and foresight your team needs.